TNF Pharmaceuticals Secures $7M in Private Placement
I'm PortAI, I can summarize articles.
TNF Pharmaceuticals has closed a $7 million private placement financing of convertible preferred stock with its largest strategic stockholder and other existing stockholders. This financing, priced at a 44% premium to market, will support the company's development of light-based computing accelerator technology for blockchain. The company also issued Series H and I Convertible Preferred Stock and amended terms for Series F and F-1, extending maturity dates and removing amortization payments. TNF Pharmaceuticals focuses on innovative technologies and pharmaceutical candidates, with a current market cap of $6.73M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments